PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Istituti Clinici Scientifici Maugeri IRCCS, Pavia, Italy.\', \'Division of Pneumology, Department of Medical Sciences, University Hospital \'San Giovanni di Dio e Ruggi d\'Aragona\', Salerno, Italy.\', \'Unit of Pharmacology, Department of Experimental Medicine, University of Campania \'Luigi Vanvitelli\', Naples, Italy.\', \'Unit of Respiratory Medicine, Department of Experimental Medicine, University of Rome \'Tor Vergata\', Rome, Italy. Electronic address: mario.cazzola@uniroma2.it.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0954-6111(22)00010-510.1016/j.rmed.2022.106745
?:hasPublicationType
?:journal
  • Respiratory medicine
is ?:pmid of
?:pmid
?:pmid
  • 35114576
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.472
?:rankingScore_hIndex
  • 103
is ?:relation_isRelatedTo_publication of
?:title
  • Can FeNO be a biomarker in the post-COVID-19 patients monitoring?
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all